Reinforcement Learning for Personalized Treatment Recommendation Systems

Personalized treatment recommendation systems have become a major focus of modern healthcare informatics because conventional clinical decision-making often relies on generalized treatment guidelines that cannot adequately accommodate individual patient heterogeneity. Variations in demographic characteristics, disease progression, genetic predisposition, comorbidities, treatment adherence, and longitudinal clinical responses necessitate intelligent decision-support systems capable of recommending adaptive therapeutic interventions. Reinforcement Learning (RL), a branch of artificial intelligence that learns optimal sequential decision policies through interactions with an environment, has emerged as a promising computational paradigm for personalized medicine. Unlike traditional predictive models that estimate clinical outcomes independently, RL continuously evaluates treatment consequences over time and identifies strategies that maximize cumulative patient benefit while minimizing adverse events.

The growing availability of electronic health records, observational clinical databases, standardized healthcare data models, and real-world evidence has accelerated research on RL-driven treatment optimization. However, practical implementation remains constrained by data quality, privacy protection, observational bias, model interpretability, and clinical acceptance. Furthermore, translating algorithmic recommendations into trustworthy medical decisions requires robust governance, transparent validation, and integration with established healthcare workflows.

This research and review article critically examines reinforcement learning for personalized treatment recommendation systems by synthesizing contemporary literature on health informatics, observational healthcare databases, technology acceptance, and clinical decision support. The study develops an integrated analytical framework connecting reinforcement learning methodologies with real-world healthcare infrastructures and technology adoption theories. Special attention is given to standardized observational data repositories, electronic health record integration, physician acceptance of intelligent decision-support technologies, cybersecurity considerations, and regulatory requirements. The analysis demonstrates that successful implementation depends not only on algorithmic performance but also on healthcare data quality, clinician trust, system usability, regulatory compliance, and secure digital infrastructure. The paper concludes by identifying current research limitations and proposing future directions toward clinically reliable, explainable, and patient-centered reinforcement learning systems capable of supporting precision medicine.

Reinforcement Learning, Personalized Medicine, Clinical Decision Support Systems, Electronic Health Records, Healthcare Informatics, Artificial Intelligence, Precision Healthcare, Treatment Recommendation, Observational Data, Technology Acceptance Model

Akpan N. Has health care hacking become an epidemic? [Internet]. Arlington (VA): PBS NewsHour; 2016 [cited at 2022 Mar 30]. Available from: https://www.pbs.org/newshour/science/has-health-care-hacking-become-an-epidemic.

Alkhateeb FM, Doucette WR. Electronic detailing (e‐detailing) of pharmaceuticals to physicians: a review. Int J Pharm Healthc Mark 2008;2(3):235-45.

Chen SC, Shing-Han L, Chien-Yi L. Recent related research in technology acceptance model: a literature review. Aust J Bus Manag Res 2011;1(9):124-7.

Davis FD. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Q 1989;13(3):319-40.

Fishbein MA, Ajzen I. Belief, attitude, intention and behavior: an introduction to theory and research. Addison-Wesley (MA): Reading; 1975.

Flynn LR, Goldsmith RE. A validation of the Goldsmith and Hofacker innovativeness scale. Educ Psychol Meas 1993;53(4):1105-16.

Franklin JM, Glynn RJ, Martin D, Schneeweiss S. Evaluating the use of nonrandomized real-world data analyses for regulatory decision making. Clin Pharmacol Ther 2019;105(4):867-77.

Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet 2002;359(9302):248-52.

Ikeda S. Wave of cyber attacks hits US healthcare system as FBI warns of coordinated criminal campaign [Internet]. Singapore: CPO Magazine; 2020 [cited at 2022 Mar 30]. Available from: https://www.cpomagazine.com/cyber-security/wave-of-cyber-attacks-hits-us-healthcare-system-as-fbi-warns-of-coordinated-criminal-campaign/.

Kassam A. Spain will register people who refuse Covid vaccine, says health minister [Internet]. London, UK: The Guardian; 2020 [cited at 2022 Mar 30]. Available from: https://www.theguardian.com/world/2020/dec/29/spain-to-keep-registry-of-people-who-refuse-covid-vaccine.

Koivisto K, Makkonen M, Frank L, Riekkinen J. Extending the technology acceptance model with personal innovativeness and technology readiness: a comparison of three models. Proceedings of the 29th Bled eConference “Digital Economy”; 2016 Jun 19-22; Bled, Slovenia. p. 113-28.

Kwak ES, Chang H. Medical representatives’ intention to use information technology in pharmaceutical marketing. Healthc Inform Res 2016;22(4):342-50.

Lallie HS, Shepherd LA, Nurse JR, Erola A, Epiphaniou G, Maple C, et al. Cyber security in the age of COVID-19: a timeline and analysis of cyber-crime and cyber-attacks during the pandemic. Computers & Security 2021;105:102248.

Maier C, Lang L, Storf H, Vormstein P, Bieber R, Bernarding J, et al. Towards implementation of OMOP in a German university hospital consortium. Appl Clin Inform 2018;9(1):54-61.

Marangunic N, Granic A. Technology acceptance model: a literature review from 1986 to 2013. Univers Access Inf Soc 2015;14(1):81-95.

Midgley DF, Dowling GR. Innovativeness: the concept and its measurement. J Consum Res 1978;4(4):229-42.

Miller DP Jr, Latulipe C, Melius KA, Quandt SA, Arcury TA. Primary care providers’ views of patient portals: interview study of perceived benefits and consequences. J Med Internet Res 2016;18(1):e8.

Muthuppalaniappan M, Stevenson K. Healthcare cyberattacks and the COVID-19 pandemic: an urgent threat to global health. Int J Qual Health Care 2021;33(1):mzaa117.

Nausheen F, Begum SH. Healthcare IoT: benefits, vulnerabilities and solutions. Proceedings of 2018 2nd International Conference on Inventive Systems and Control (ICISC); 2017 Jan 19-20; Coimbatore, India. p. 517-22.

Observational Health Data Sciences and Informatics. The book of OHDSI [Internet]. [place unknown]: Observational Health Data Sciences and Informatics; 2021 [cited at 2022 Apr 15]. Available from: https://ohdsi.github.io/TheBookOfOhdsi/.

Rahimi B, Nadri H, Lotfnezhad Afshar H, Timpka T. A systematic review of the technology acceptance model in health informatics. Appl Clin Inform 2018;9(3):604-34.

Reisinger SJ, Ryan PB, O’Hara DJ, Powell GE, Painter JL, Pattishall EN, et al. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc 2010;17(6):652-62.

Rogers EM. Diffusion of innovations. 5th ed. New York (NY): Free Press; 2003.

Schneeweiss S, Glynn RJ. Real-world data analytics fit for regulatory decision-making. Am J Law Med 2018;44(2-3):197-217.

Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019;394(10211):1816-26.

Weiskopf NG, Bakken S, Hripcsak G, Weng C. A data quality assessment guideline for electronic health record data reuse. EGEMS (Wash DC) 2017;5(1):14.

You SC, Rho Y, Bikdeli B, Kim J, Siapos A, Weaver J, et al. Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA 2020;324(16):1640-50.